Bariatric surgery was found to be safe for patients with congestive heart failure.
Long-term outcomes of unprotected left main percutaneous coronary intervention were found to be favorable.
According to the FDA’s safety communication, multiple factors may affect the accuracy of pulse oximeter readings, including poor circulation, skin pigmentation, skin thickness, skin temperature, current tobacco use, and use of fingernail polish.
Exercise real-time CMR was found to represent an effective, non-invasive alternative to right heart catherization for the diagnosis of HFpEF.
A 12-week treatment with empagliflozin was associated with reductions in extracellular volume, estimated plasma volume, and GFR in patients with HFrEF.
Update by ACC to its 2017 Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment.
This kit will be Walgreens first OTC COVID-19 testing option available for purchase in-store at the pharmacy counter.
The Canadian Transient Ischemic Attack (TIA) Score effectively stratifies seven-day stroke risk among emergency department patients with TIA.
Polynesian ancestry in Native Hawaiians seems to be associated with an increased risk for obesity, type 2 diabetes.
Patients with heart failure are at high risk for severe COVID-19 presentation.
The NIAID will evaluate the vaccine candidate, mRNA-1273.351, against the SARS-CoV-2 variant, B.1.351.
Cancer is now the leading contributor to death among individuals with diabetes living in England.
Cocaine use and HIV infection are associated with radiomic features quantified for coronary plaque morphology.
February is American Heart Month, and patients who have been diagnosed with cancer are part of a group that is uniquely vulnerable to cardiovascular disease. What risk factors should these patients know about for fatal heart disease?
Occurrence of new-onset AF in the month following AMI was found to be associated with elevated risks for death and ischemic stroke.
Transient resumption of at least 1 cycle of cardiac activity after pulselessness was observed in 14% of patients after withdrawal of life-sustaining measures.
Among patients who were not made DNR and did not have withdrawal of life-sustaining therapy, women had lower discharge survival.
Elevated NT-proBNP may represent a useful biomarker for the identification of individuals at high risk for CVD and mortality across the spectrum of blood and pulse pressures.
Exercise Doppler echocardiography may provide consistent assessment of right heart function and pulmonary circulation when conducted at expert centers.
Avacopan is noninferior, but not superior, to prednisone with respect to remission at week 26 for patients with antineutrophil cytoplasmic antibody associated vasculitis.